- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2021 growth of Pd-1 and Pd-L1 Inhibitors will have significant change from previous year. By the most conservative estimates of global Pd-1 and Pd-L1 Inhibitors market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Pd-1 and Pd-L1 Inhibitors market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Pd-1 and Pd-L1 Inhibitors market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
PD-1
PD-L1
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital Pharmacies
Retail Pharmacies
Specialty Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Bristol-Myers Squibb
Merck
F. Hoffmann-La Roche
Sanofi
Amgen
Gilead Sciences
AstraZeneca
Novartis
Pfizer
Celgene
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pd-1 and Pd-L1 Inhibitors Consumption 2016-2026
2.1.2 Pd-1 and Pd-L1 Inhibitors Consumption CAGR by Region
2.2 Pd-1 and Pd-L1 Inhibitors Segment by Type
2.2.1 PD-1
2.2.2 PD-L1
2.3 Pd-1 and Pd-L1 Inhibitors Sales by Type
2.3.1 Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type (2016-2021)
2.3.2 Global Pd-1 and Pd-L1 Inhibitors Revenue and Market Share by Type (2016-2021)
2.3.3 Global Pd-1 and Pd-L1 Inhibitors Sale Price by Type (2016-2021)
2.4 Pd-1 and Pd-L1 Inhibitors Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Specialty Pharmacies
2.5 Pd-1 and Pd-L1 Inhibitors Sales by Application
2.5.1 Global Pd-1 and Pd-L1 Inhibitors Sale Market Share by Application (2016-2021)
2.5.2 Global Pd-1 and Pd-L1 Inhibitors Revenue and Market Share by Application (2016-2021)
2.5.3 Global Pd-1 and Pd-L1 Inhibitors Sale Price by Application (2016-2021)
3 Global Pd-1 and Pd-L1 Inhibitors by Company
3.1 Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Company
3.1.1 Global Pd-1 and Pd-L1 Inhibitors Sales by Company (2019-2021)
3.1.2 Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Company (2019-2021)
3.2 Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Company
3.2.1 Global Pd-1 and Pd-L1 Inhibitors Revenue by Company (2019-2021)
3.2.2 Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Company (2019-2021)
3.3 Global Pd-1 and Pd-L1 Inhibitors Sale Price by Company
3.4 Global Manufacturers Pd-1 and Pd-L1 Inhibitors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pd-1 and Pd-L1 Inhibitors Product Location Distribution
3.4.2 Players Pd-1 and Pd-L1 Inhibitors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Pd-1 and Pd-L1 Inhibitors by Region
4.1 Global Pd-1 and Pd-L1 Inhibitors by Region
4.1.1 Global Pd-1 and Pd-L1 Inhibitors Sales by Region
4.1.2 Global Pd-1 and Pd-L1 Inhibitors Revenue by Region
4.2 Americas Pd-1 and Pd-L1 Inhibitors Sales Growth
4.3 APAC Pd-1 and Pd-L1 Inhibitors Sales Growth
4.4 Europe Pd-1 and Pd-L1 Inhibitors Sales Growth
4.5 Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Growth
5 Americas
5.1 Americas Pd-1 and Pd-L1 Inhibitors Sales by Country
5.1.1 Americas Pd-1 and Pd-L1 Inhibitors Sales by Country (2016-2021)
5.1.2 Americas Pd-1 and Pd-L1 Inhibitors Revenue by Country (2016-2021)
5.2 Americas Pd-1 and Pd-L1 Inhibitors Sales by Type
5.3 Americas Pd-1 and Pd-L1 Inhibitors Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pd-1 and Pd-L1 Inhibitors Sales by Region
6.1.1 APAC Pd-1 and Pd-L1 Inhibitors Sales by Region (2016-2021)
6.1.2 APAC Pd-1 and Pd-L1 Inhibitors Revenue by Region (2016-2021)
6.2 APAC Pd-1 and Pd-L1 Inhibitors Sales by Type
6.3 APAC Pd-1 and Pd-L1 Inhibitors Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pd-1 and Pd-L1 Inhibitors by Country
7.1.1 Europe Pd-1 and Pd-L1 Inhibitors Sales by Country (2016-2021)
7.1.2 Europe Pd-1 and Pd-L1 Inhibitors Revenue by Country (2016-2021)
7.2 Europe Pd-1 and Pd-L1 Inhibitors Sales by Type
7.3 Europe Pd-1 and Pd-L1 Inhibitors Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pd-1 and Pd-L1 Inhibitors by Country
8.1.1 Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales by Country (2016-2021)
8.1.2 Middle East & Africa Pd-1 and Pd-L1 Inhibitors Revenue by Country (2016-2021)
8.2 Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales by Type
8.3 Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Pd-1 and Pd-L1 Inhibitors Distributors
10.3 Pd-1 and Pd-L1 Inhibitors Customer
11 Global Pd-1 and Pd-L1 Inhibitors Market Forecast
11.1 Global Pd-1 and Pd-L1 Inhibitors Forecast by Region
11.1.1 Global Pd-1 and Pd-L1 Inhibitors Forecast by Regions (2021-2026)
11.2.2 Global Pd-1 and Pd-L1 Inhibitors Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Pd-1 and Pd-L1 Inhibitors Forecast by Type
11.7 Global Pd-1 and Pd-L1 Inhibitors Forecast by Application
12 Key Players Analysis
12.1 Bristol-Myers Squibb
12.1.1 Bristol-Myers Squibb Company Information
12.1.2 Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Product Offered
12.1.3 Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Bristol-Myers Squibb Main Business Overview
12.1.5 Bristol-Myers Squibb Latest Developments
12.2 Merck
12.2.1 Merck Company Information
12.2.2 Merck Pd-1 and Pd-L1 Inhibitors Product Offered
12.2.3 Merck Pd-1 and Pd-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Merck Main Business Overview
12.2.5 Merck Latest Developments
12.3 F. Hoffmann-La Roche
12.3.1 F. Hoffmann-La Roche Company Information
12.3.2 F. Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Product Offered
12.3.3 F. Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 F. Hoffmann-La Roche Main Business Overview
12.3.5 F. Hoffmann-La Roche Latest Developments
12.4 Sanofi
12.4.1 Sanofi Company Information
12.4.2 Sanofi Pd-1 and Pd-L1 Inhibitors Product Offered
12.4.3 Sanofi Pd-1 and Pd-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Sanofi Main Business Overview
12.4.5 Sanofi Latest Developments
12.5 Amgen
12.5.1 Amgen Company Information
12.5.2 Amgen Pd-1 and Pd-L1 Inhibitors Product Offered
12.5.3 Amgen Pd-1 and Pd-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Amgen Main Business Overview
12.5.5 Amgen Latest Developments
12.6 Gilead Sciences
12.6.1 Gilead Sciences Company Information
12.6.2 Gilead Sciences Pd-1 and Pd-L1 Inhibitors Product Offered
12.6.3 Gilead Sciences Pd-1 and Pd-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Gilead Sciences Main Business Overview
12.6.5 Gilead Sciences Latest Developments
12.7 AstraZeneca
12.7.1 AstraZeneca Company Information
12.7.2 AstraZeneca Pd-1 and Pd-L1 Inhibitors Product Offered
12.7.3 AstraZeneca Pd-1 and Pd-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 AstraZeneca Main Business Overview
12.7.5 AstraZeneca Latest Developments
12.8 Novartis
12.8.1 Novartis Company Information
12.8.2 Novartis Pd-1 and Pd-L1 Inhibitors Product Offered
12.8.3 Novartis Pd-1 and Pd-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Novartis Main Business Overview
12.8.5 Novartis Latest Developments
12.9 Pfizer
12.9.1 Pfizer Company Information
12.9.2 Pfizer Pd-1 and Pd-L1 Inhibitors Product Offered
12.9.3 Pfizer Pd-1 and Pd-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Pfizer Main Business Overview
12.9.5 Pfizer Latest Developments
12.10 Celgene
12.10.1 Celgene Company Information
12.10.2 Celgene Pd-1 and Pd-L1 Inhibitors Product Offered
12.10.3 Celgene Pd-1 and Pd-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Celgene Main Business Overview
12.10.5 Celgene Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Pd-1 and Pd-L1 Inhibitors Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of PD-1
Table 3. Major Players of PD-L1
Table 4. Global Pd-1 and Pd-L1 Inhibitors Sales by Type (2016-2021) & (K Units)
Table 5. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type (2016-2021)
Table 6. Global Pd-1 and Pd-L1 Inhibitors Revenue by Type (2016-2021) & ($ million)
Table 7. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Type (2016-2021)
Table 8. Global Pd-1 and Pd-L1 Inhibitors Sale Price by Type (2016-2021)
Table 9. Global Pd-1 and Pd-L1 Inhibitors Sales by Application (2016-2021) & (K Units)
Table 10. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application (2016-2021)
Table 11. Global Pd-1 and Pd-L1 Inhibitors Value by Application (2016-2021)
Table 12. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Application (2016-2021)
Table 13. Global Pd-1 and Pd-L1 Inhibitors Sale Price by Application (2016-2021)
Table 14. Global Pd-1 and Pd-L1 Inhibitors Sales by Company (2019-2021) & (K Units)
Table 15. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Company (2019-2021)
Table 16. Global Pd-1 and Pd-L1 Inhibitors Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Company (2019-2021)
Table 18. Global Pd-1 and Pd-L1 Inhibitors Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Pd-1 and Pd-L1 Inhibitors Producing Area Distribution and Sales Area
Table 20. Players Pd-1 and Pd-L1 Inhibitors Products Offered
Table 21. Pd-1 and Pd-L1 Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Pd-1 and Pd-L1 Inhibitors Sales by Region (2016-2021) (K Units)
Table 25. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Region (2016-2021)
Table 26. Global Pd-1 and Pd-L1 Inhibitors Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Region (2016-2021)
Table 28. Americas Pd-1 and Pd-L1 Inhibitors Sales by Country (2016-2021) & (K Units)
Table 29. Americas Pd-1 and Pd-L1 Inhibitors Sales Market Share by Country (2016-2021)
Table 30. Americas Pd-1 and Pd-L1 Inhibitors Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Country (2016-2021)
Table 32. Americas Pd-1 and Pd-L1 Inhibitors Sales by Type (2016-2021) & (K Units)
Table 33. Americas Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type (2016-2021)
Table 34. Americas Pd-1 and Pd-L1 Inhibitors Sales by Application (2016-2021) & (K Units)
Table 35. Americas Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application (2016-2021)
Table 36. APAC Pd-1 and Pd-L1 Inhibitors Sales by Region (2016-2021) & (K Units)
Table 37. APAC Pd-1 and Pd-L1 Inhibitors Sales Market Share by Region (2016-2021)
Table 38. APAC Pd-1 and Pd-L1 Inhibitors Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Region (2016-2021)
Table 40. APAC Pd-1 and Pd-L1 Inhibitors Sales by Type (2016-2021) & (K Units)
Table 41. APAC Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type (2016-2021)
Table 42. APAC Pd-1 and Pd-L1 Inhibitors Sales by Application (2016-2021) & (K Units)
Table 43. APAC Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application (2016-2021)
Table 44. Europe Pd-1 and Pd-L1 Inhibitors Sales by Country (2016-2021) & (K Units)
Table 45. Europe Pd-1 and Pd-L1 Inhibitors Sales Market Share by Country (2016-2021)
Table 46. Europe Pd-1 and Pd-L1 Inhibitors Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Country (2016-2021)
Table 48. Europe Pd-1 and Pd-L1 Inhibitors Sales by Type (2016-2021) & (K Units)
Table 49. Europe Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type (2016-2021)
Table 50. Europe Pd-1 and Pd-L1 Inhibitors Sales by Application (2016-2021) & (K Units)
Table 51. Europe Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Pd-1 and Pd-L1 Inhibitors
Table 61. Key Application and Potential Industries of Pd-1 and Pd-L1 Inhibitors
Table 62. Key Challenges of Pd-1 and Pd-L1 Inhibitors
Table 63. Key Trends of Pd-1 and Pd-L1 Inhibitors
Table 64. Pd-1 and Pd-L1 Inhibitors Distributors List
Table 65. Pd-1 and Pd-L1 Inhibitors Customer List
Table 66. Global Pd-1 and Pd-L1 Inhibitors Sales Forecast by Region (2021-2026) & (K Units)
Table 67. Global Pd-1 and Pd-L1 Inhibitors Consumption Market Forecast by Region
Table 68. Global Pd-1 and Pd-L1 Inhibitors Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Pd-1 and Pd-L1 Inhibitors Sales Forecast by Country (2021-2026) & (K Units)
Table 71. Americas Pd-1 and Pd-L1 Inhibitors Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Pd-1 and Pd-L1 Inhibitors Sales Forecast by Region (2021-2026) & (K Units)
Table 73. APAC Pd-1 and Pd-L1 Inhibitors Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Pd-1 and Pd-L1 Inhibitors Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Europe Pd-1 and Pd-L1 Inhibitors Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Pd-1 and Pd-L1 Inhibitors Sales Forecast by Type (2021-2026) & (K Units)
Table 79. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Pd-1 and Pd-L1 Inhibitors Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Pd-1 and Pd-L1 Inhibitors Sales Forecast by Application (2021-2026) & (K Units)
Table 83. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Pd-1 and Pd-L1 Inhibitors Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share Forecast by Application (2021-2026)
Table 86. Bristol-Myers Squibb Basic Information, Pd-1 and Pd-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 87. Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Product Offered
Table 88. Bristol-Myers Squibb Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 89. Bristol-Myers Squibb Main Business
Table 90. Bristol-Myers Squibb Latest Developments
Table 91. Merck Basic Information, Pd-1 and Pd-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 92. Merck Pd-1 and Pd-L1 Inhibitors Product Offered
Table 93. Merck Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 94. Merck Main Business
Table 95. Merck Latest Developments
Table 96. F. Hoffmann-La Roche Basic Information, Pd-1 and Pd-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 97. F. Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Product Offered
Table 98. F. Hoffmann-La Roche Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 99. F. Hoffmann-La Roche Main Business
Table 100. F. Hoffmann-La Roche Latest Developments
Table 101. Sanofi Basic Information, Pd-1 and Pd-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 102. Sanofi Pd-1 and Pd-L1 Inhibitors Product Offered
Table 103. Sanofi Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 104. Sanofi Main Business
Table 105. Sanofi Latest Developments
Table 106. Amgen Basic Information, Pd-1 and Pd-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 107. Amgen Pd-1 and Pd-L1 Inhibitors Product Offered
Table 108. Amgen Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 109. Amgen Main Business
Table 110. Amgen Latest Developments
Table 111. Gilead Sciences Basic Information, Pd-1 and Pd-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 112. Gilead Sciences Pd-1 and Pd-L1 Inhibitors Product Offered
Table 113. Gilead Sciences Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 114. Gilead Sciences Main Business
Table 115. Gilead Sciences Latest Developments
Table 116. AstraZeneca Basic Information, Pd-1 and Pd-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 117. AstraZeneca Pd-1 and Pd-L1 Inhibitors Product Offered
Table 118. AstraZeneca Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 119. AstraZeneca Main Business
Table 120. AstraZeneca Latest Developments
Table 121. Novartis Basic Information, Pd-1 and Pd-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 122. Novartis Pd-1 and Pd-L1 Inhibitors Product Offered
Table 123. Novartis Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 124. Novartis Main Business
Table 125. Novartis Latest Developments
Table 126. Pfizer Basic Information, Pd-1 and Pd-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 127. Pfizer Pd-1 and Pd-L1 Inhibitors Product Offered
Table 128. Pfizer Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 129. Pfizer Main Business
Table 130. Pfizer Latest Developments
Table 131. Celgene Basic Information, Pd-1 and Pd-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
Table 132. Celgene Pd-1 and Pd-L1 Inhibitors Product Offered
Table 133. Celgene Pd-1 and Pd-L1 Inhibitors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 134. Celgene Main Business
Table 135. Celgene Latest Developments
List of Figures
Figure 1. Picture of Pd-1 and Pd-L1 Inhibitors
Figure 2. Pd-1 and Pd-L1 Inhibitors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pd-1 and Pd-L1 Inhibitors Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Pd-1 and Pd-L1 Inhibitors Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Pd-1 and Pd-L1 Inhibitors Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of PD-1
Figure 10. Product Picture of PD-L1
Figure 11. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type in 2020
Figure 12. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Type (2016-2021)
Figure 13. Pd-1 and Pd-L1 Inhibitors Consumed in Hospital Pharmacies
Figure 14. Global Pd-1 and Pd-L1 Inhibitors Market: Hospital Pharmacies (2016-2021) & (K Units)
Figure 15. Pd-1 and Pd-L1 Inhibitors Consumed in Retail Pharmacies
Figure 16. Global Pd-1 and Pd-L1 Inhibitors Market: Retail Pharmacies (2016-2021) & (K Units)
Figure 17. Pd-1 and Pd-L1 Inhibitors Consumed in Specialty Pharmacies
Figure 18. Global Pd-1 and Pd-L1 Inhibitors Market: Specialty Pharmacies (2016-2021) & (K Units)
Figure 19. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application (2016-2021)
Figure 20. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Application in 2020
Figure 21. Pd-1 and Pd-L1 Inhibitors Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Company in 2020
Figure 23. Global Pd-1 and Pd-L1 Inhibitors Sales Market Share by Regions (2016-2021)
Figure 24. Global Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Region in 2020
Figure 25. Americas Pd-1 and Pd-L1 Inhibitors Sales 2016-2021 (K Units)
Figure 26. Americas Pd-1 and Pd-L1 Inhibitors Revenue 2016-2021 ($ Millions)
Figure 27. APAC Pd-1 and Pd-L1 Inhibitors Sales 2016-2021 (K Units)
Figure 28. APAC Pd-1 and Pd-L1 Inhibitors Revenue 2016-2021 ($ Millions)
Figure 29. Europe Pd-1 and Pd-L1 Inhibitors Sales 2016-2021 (K Units)
Figure 30. Europe Pd-1 and Pd-L1 Inhibitors Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales 2016-2021 (K Units)
Figure 32. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Revenue 2016-2021 ($ Millions)
Figure 33. Americas Pd-1 and Pd-L1 Inhibitors Sales Market Share by Country in 2020
Figure 34. Americas Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Country in 2020
Figure 35. Americas Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type in 2020
Figure 36. Americas Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application in 2020
Figure 37. United States Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Pd-1 and Pd-L1 Inhibitors Sales Market Share by Region in 2020
Figure 42. APAC Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Regions in 2020
Figure 43. APAC Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type in 2020
Figure 44. APAC Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application in 2020
Figure 45. China Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Pd-1 and Pd-L1 Inhibitors Sales Market Share by Country in 2020
Figure 52. Europe Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Country in 2020
Figure 53. Europe Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type in 2020
Figure 54. Europe Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application in 2020
Figure 55. Germany Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Pd-1 and Pd-L1 Inhibitors Sales Market Share by Application in 2020
Figure 64. Egypt Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Pd-1 and Pd-L1 Inhibitors Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
